• G-III Apparel (GIII) and Ambarella (AMBA) Beat Consensus; Insider Bets on Heron Therapeutics (HRTX)

    G-III Apparel Group, Ltd. (GIII) Shares of GIII surged to reach a new 52-week high in after-hours trading Tuesday as the company delivered quarterly profit and revenue above Wall Street analysts’ expectations. For its first quarter fiscal 2016, GIII posted net sales of $433.0 million, an 18% increase year over year, and net income of $6.8 million, or $0.15 per diluted share, compared to net income of $1.3 million, or $0.03 per diluted share in the same quarter the prior year, topping the Capital IQ Consensus Estimate of $0.07 earnings per share on revenues of $405.76 million for the period. The company has raised its guidance for the f
  • PVH Corp (PVH) Posts Surprise Profit; Larry Robbins Sees Potential in Manitowoc (MTW)

    PVH Corp. (PVH) PVH delivered stronger-than-expected quarterly profit in its financial results, driven by the strength of its Calvin Klein business. For the first quarter 2015, posted revenues of $1.88 billion, a 4.3% decrease year over year, and non-GAAP net income of $124.7 million, or $1.50 per diluted share, compared to non-GAAP net income of $122.1 million, or $1.47 per diluted share in the same quarter the prior year, exceeding the Capital IQ Consensus of $1.38 earnings per share on revenues of $1.86 billion for the period PVH has raised its non-GAAP EPS guidance for the full year 2015 to a range of $6.85 to $6.95 from the previously r
  • Strong Biotech-Momentum Indicators: Oncothyreon (ONTY), Exelixis (EXEL), Tesaro (TSRO)

    Oncothyreon Inc (ONTY) Shares of ONTY soared to reach a new 52-week high in pre-market trading Monday, after the company reported positive data from its ongoing trials of ONT-380, an orally active, reversible and selective small-molecule HER2 inhibitor for the treatment of breast cancer. ONT-380 has been well tolerated in both Phase 1b trials, an important consideration in patients who may need prolonged therapy According to ONTY, data from the Phase 1b trial of ONT-380 in combination with Xeloda(R) (capecitabine) and Herceptin(R) (trastuzumab) in third line treatment of HER2-positive metastatic breast cancer support its plans to initiate a
  • Interesting Stock Signals: Altera (ALTR), AbbVie (ABBV), Integrated Silicon Solution (ISSI)

    Altera Corp. (ALTR) Shares of ALTR touched anew 52-week high in after-hours trading Friday, continuing the positive momentum generated by media reports indicating that tech giant Intel Corp. (INTC) is near a deal to acquire the company for as much as $54.00 per share. ALTR posted sales of $435.5 million and net income of $94.9 million, or $0.31 per diluted share for the first quarter 2015 ALTR, a semiconductor company, designs and sells programmable logic devices (PLDs), HardCopy application-specific integrated circuit (ASIC) devices, power system-on-chip devices (PowerSoCs), pre-defined design building blocks, and associated development to
  • Stake Bets: Point72 on Achillion (ACHN), Stonepine Capital on Aegerion (AEGR), CPP Investment Board on Enstar (ESGR)

    Achillion Pharmaceuticals, Inc. (ACHN) In a new filing (SC 13G) with the Securities and Exchange Commission (SEC), billionaire Steve Cohen’s Point72 Asset Management, L.P. has disclosed a 5% (5,879,244 shares) stake in ACHN . ACHN recently announced an agreement with Janssen Pharmaceuticals to develop and commercialize one or more of ACHN‘s lead hepatitis C virus (HCV) assets, including ACH-3102, ACH-3422, and sovaprevir. According to the company, the deal calls for up to $1.1 billion in potential development, regulatory and sales milestone payments and a separate equity investment. ACHN, a biopharmaceutical company, focuses on
  • Heron Therapeutics (HRTX) Momentum on Top-Line Study Results; Is Rosetta Stone (RST) a Takeover Target?

    Heron Therapeutics, Inc. (HRTX) Shares of HRTX soared to reach a record high in extended-hours trading Thursday after the company reported positive, top-line results from its recently completed Phase 3 MAGIC study. According to HRTX, its 5-HT3 receptor antagonist product candidate SUSTOL (granisetron injection, extended release), as part of a three-drug regimen, demonstrated superiority to the currently recommended standard-of-care, three-drug regimen (which uses ondansetron as 5-HT3 receptor antagonist) for delayed nausea and vomiting after administration of highly emetogenic chemotherapy agents. HRTX also said that SUSTOL-based regimen was

Stock Highlights

G-III Apparel (GIII) and Ambarella (AMBA) Beat Consensus; Insider Bets on Heron Therapeutics (HRTX)

02 Jun 2015 10:39 | Featured 1 (500x300), Stock Highlights

G-III Apparel Group, Ltd. (GIII) Shares of GIII surged to reach a new 52-week high in after-hours trading Tuesday as the company delivered quarterly profit and revenue above Wall Street analysts’ expectations. For its first quarter fiscal 2016, GIII pos ... | Read

PVH Corp (PVH) Posts Surprise Profit; Larry Robbins Sees Potential in Manitowoc (MTW)

01 Jun 2015 08:42 | Featured 1 (500x300), Stock Highlights

PVH Corp. (PVH) PVH delivered stronger-than-expected quarterly profit in its financial results, driven by the strength of its Calvin Klein business. For the first quarter 2015, posted revenues of $1.88 billion, a 4.3% decrease year over year, and non-GAAP net ... | Read

Strong Biotech-Momentum Indicators: Oncothyreon (ONTY), Exelixis (EXEL), Tesaro (TSRO)

01 Jun 2015 07:02 | Featured 1 (500x300), Stock Highlights

Oncothyreon Inc (ONTY) Shares of ONTY soared to reach a new 52-week high in pre-market trading Monday, after the company reported positive data from its ongoing trials of ONT-380, an orally active, reversible and selective small-molecule HER2 inhibitor for th ... | Read

Business News

O&T Success LLC Laundry Bag With 2inch Shoulder Strap Blue Is Available On Amazon

03 Jun 2015 01:00 | Business News

(EMAILWIRE.COM, June 03, 2015 ) Miami, FL -- YaeloDesign is Launching their own Laundry Bag. Yaelo Design's Laundr Bag measure 30x40 inches. The Laundry Bag That Can Carry All of the Laundry Stuff ... | Read

  O&T Success LLC Introduces A New Product On Amazon
  03 Jun 2015 01:00
   
  CS Athletic Gear Announces Availability Of Muscle Mower On Amazon.com
  03 Jun 2015 01:00
   

Health & Medical

Furiex Pharmaceuticals Announces Positive Top-Line Results of Two Pivotal Phase III Clinical Trials of Eluxadoline in Patients with IBS-d

04 Feb 2014 08:42 | Health & Medical, Stock Highlights

Studies Meet FDA and EMA Primary Endpoints Conference Call and Webcast Scheduled for 8:30 a.m. ET Today MORRISVILLE, N.C. Feb. 4, 2014 - (CRWE Press Release) - Furiex Pharmaceuticals, Inc. (NASDAQ: F ... | Read

  Luna announces sale of shape-sensing technology for medical applications
  22 Jan 2014 15:52
   
  Rosetta Genomics Announces Master Service Provider Agreement With a Major, Global Biopharmaceutical Company
  13 Jan 2014 12:21
   

Politics

Obama Speaks To Iranian President Hassan Rouhani in New York

27 Sep 2013 03:04 | Featured 1 (500x300), Politics

For the first time in over 30 years, the two heads of states of the United States and Iran have had direct communication. It was the first step in efforts to discuss negotiations regarding Iran's ... | Read

  Media Users On Politics
  26 Sep 2013 13:43
   
  Anthony Weiner, A Sore Loser
  11 Sep 2013 11:21
   

Recents News

Silver Shield Resources Corp., Announces Share Consolidation

June 3rd, 2015

OM GROUP SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of OM Group Inc. (OMG) Over the Proposed Sale of the Company to Apollo Global Management Affiliates

June 3rd, 2015

SFX SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of SFX Entertainment Inc. (SFXE) Over the Proposed Sale of the Company in a Going Private Transaction with the Company CEO

June 3rd, 2015

Written testimony of PRIV Chief Privacy Officer for a House Committee on Oversight and Government Reform hearing titled “Ensuring Agency Compliance with the Freedom of Information Act (FOIA)”

June 3rd, 2015

Eastcoal Inc.: Appointment of Chief Financial Officer and Other Management Changes

June 3rd, 2015

2015 Hurricane and Typhoon Season

June 3rd, 2015
  • CRWE Network

  •